Foundation Medicine, Inc.
NASDAQTotal Valuation
Foundation Medicine, Inc. carries a market capitalization of - -, placing it among publicly traded companies globally. Its enterprise value stands at 5.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | - - |
| Enterprise Value | 5.06B |
Share Statistics
Foundation Medicine, Inc. currently has 37.15M shares outstanding.
| Shares Outstanding | 37.15M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 24.82, and the price-to-book ratio stands at -8.95.
| PE Ratio | N/A |
| PS Ratio | 24.82 |
| PB Ratio | -8.95 |
| P/TBV Ratio | -585.62 |
| P/FCF Ratio | -54.18 |
| P/OCF Ratio | -43.77 |
Enterprise Valuation
| EV / Sales | 25.10 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Foundation Medicine, Inc. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.68 |
| Quick Ratio | 1.29 |
| Debt / Equity | -1,288.66 |
| Debt / EBITDA | -0.93 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -83.31 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.78 |
Stock Price Statistics
Foundation Medicine, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 127.81, while the 200-day moving average is 83.62.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 127.81 |
| 200-Day Moving Average | 83.62 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Foundation Medicine, Inc. generated 201.42M in revenue and converted that into -141.55M in net income, yielding earnings per share of -3.87. EBITDA reached -118.06M, while operating income came in at -138.45M.
| Revenue | 201.42M |
| Gross Profit | 101.04M |
| Operating Income | -138.45M |
| Pretax Income | -141.55M |
| Net Income | -141.55M |
| EBITDA | -118.06M |
| EBIT | -138.45M |
| Earnings Per Share (EPS) | -3.87 |
Balance Sheet
Foundation Medicine, Inc. holds 53.42M in cash and equivalents against 110.00M in total debt, resulting in a net debt position of 56.58M. Total book value stands at -558.85M, with working capital of 55.36M providing operational flexibility.
| Cash & Cash Equivalents | 53.42M |
| Total Debt | 110.00M |
| Net Debt | 56.58M |
| Equity (Book Value) | -558.85M |
| Book Value Per Share | -15.28 |
| Working Capital | 55.36M |
Cash Flow
Foundation Medicine, Inc. produced -114.21M in operating cash flow over the past twelve months. After subtracting -21.95M in capital expenditures, free cash flow totaled -136.16M - equivalent to -3.72 per share.
| Operating Cash Flow | -114.21M |
| Capital Expenditures | -21.95M |
| Free Cash Flow | -136.16M |
| FCF Per Share | -3.72 |
Margins
Foundation Medicine, Inc. operates with a gross margin of 50.17, reflecting its pricing power and cost economics. The operating margin of -68.74 and net profit margin of -70.28 provide insight into operational efficiency.
| Gross Margin | 50.17 |
| Operating Margin | -68.74 |
| Pretax Margin | -70.28 |
| Profit Margin | -70.28 |
| EBITDA Margin | -58.61 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -2.38 |
| FCF Yield | -1.85 |
Scores
Foundation Medicine, Inc. posts an Altman Z-Score of 9.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.83 |